电邮这篇文章 The possibilities of clindamycin and butoconazole containing vaginal cream in reducing the risk of recurrence of urogenital candidiasis in comorbid patients with bacterial vaginosis
- 作者: Sergiyenko GS1, Tazina TV2, Zhuchkov MV1,2
-
隶属关系:
- Ryazan State Regional Dermato-Venerological Clinic
- I.P.Pavlov Ryazan State Medical University of the Ministry of Health of the Russian Federation
- 期: 卷 20, 编号 1 (2018)
- 页面: 68-70
- 栏目: Articles
- URL: https://ogarev-online.ru/2079-5831/article/view/30049
- DOI: https://doi.org/10.26442/2079-5696_20.1.68-70
- ID: 30049
如何引用文章
全文:
详细
Purpose - a study of the efficacy of clindamycin cream with butoconazole (Clindacin B prolong) in the treatment of urogenital candidiasis in combination with bacterial vaginosis (BV) in women of reproductive age outside of pregnancy, the study of the potential of Clindacin B prolong in reducing the risk of recurrence of urogenital candidiasis in comorbid patients with BV. Material and methods. The study included 53 patients aged 18 to 45 years (mean age 31.5±9.4 years) with urogenital candidiasis in combination with BV. All women underwent antibacterial therapy with Clindacin B prolong at 1 dose (5.0 g) in the vagina at night for 3 days. Results. After 3-day therapy with Clindacin B prolong, a 100% cure effect has been achieved, both clinically and laboratory-wise. Then the patients were observed for 6 months. The relapse rate was 10.2%. The conclusion. The clinical efficacy of clindamycin cream with butoconazole (Clindacin B prolong preparation) in the treatment of urogenital candidiasis in combination with BV in women of reproductive age outside of pregnancy was 89.8% with observation for 6 months.
作者简介
G Sergiyenko
Ryazan State Regional Dermato-Venerological Clinic
Email: misha.juchkov@gmail.com
врач акушер-гинеколог высшей категории
390046, Russian Federation, Ryazan, ul. Sportivnaia, d. 9T Tazina
I.P.Pavlov Ryazan State Medical University of the Ministry of Health of the Russian Federation
编辑信件的主要联系方式.
Email: misha.juchkov@gmail.com
канд. мед. наук, ассистент каф. хирургии, акушерства и гинекологи
390026, Russian Federation, Riazan, ul. Vysokovol'tnaia, d. 9M Zhuchkov
Ryazan State Regional Dermato-Venerological Clinic; I.P.Pavlov Ryazan State Medical University of the Ministry of Health of the Russian Federation
Email: misha.juchkov@gmail.com
ассистент каф. сестринского дела, зам. глав. врача 390046, Russian Federation, Ryazan, ul. Sportivnaia, d. 9
参考
- Анкирская А.С., Муравьева В.В. Интегральная оценка состояния микробиоты влагалища. Диагностика оппортунистических вагинитов (медицинская технология). М., 2011.
- Sobel J.D, Reichman O, Misra D, Yoo W. Prognosis and Treatment of Desquamative Inflammatory Vaginiti. Obstet Gynecol 2011; 117: 850-5.
- Захарова Т.В. Бактериальный вагиноз и бактериальный вагинит: клинико-микробиологические варианты течения. Вестн. новых мед. технологий. 2008; 15 (1): 199-200.
- Sherrard J, Donders G, White D. European (IUSTI/WHO) Guideline on the Management of Vaginal Discharge. Int J STD AIDS 2011; 22: 421-9.
- Chohan V.H, Baeten J, Benki S et al. A prospective study of risk factors for herpes simplex virus Type 2 Acquisition among highrisk HIV1 Seronegative Kenyan Women. Sex Transm Infect 2009; 85: 489-92.
- Российское общество акушеров-гинекологов. Диагностика и лечение заболеваний, сопровождающихся патологическими выделениями из половых путей женщин. Клинические рекомендации. М.: ГЭОТАР-Медиа, 2013.]
- Волков В.Г., Бадаева А.А. Воспалительные изменения в последах у беременных с бактериальным вагинозом. Вестн. РУДН. Сер.: Медицина. 2012; 5: 113-6
- Олина А.А. Эпидемиологические и микробиологические аспекты неспецифических инфекционных заболеваний влагалища. Уральский мед. журн. 2008; 8: 160-3.
- Atashili J, Poole C, Ndumbe PM et al. Bacterial vaginosis and HIV acquisition: a metaanalysis of published studies. AIDS 2008; 22: 1493-501.
- Salameh S, Sheth U, Shukla D. Open Early events in herpes simplex virus lifecycle with implications for an infection of lifetime. Virol J 2012; 6: 1-6.
补充文件
